Angina in Non Coronary Artery Disease (HeartQuest)
Many patients undergoing coronary angiography are found to have no significant coronary artery disease (CAD) despite angina equivalent symptoms and/or electrocardiographic abnormalities suggestive of myocardial ischemia. The aim of this study is to systematically assess patients with angina equivalent symptoms despite normal coronary angiograms and to evaluate their symptoms according to a defined algorithm.
Angina Pectoris, Variant
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Invasive Findings in Patients With Angina Equivalent Symptoms But No Coronary Artery Disease; Results From the Heart Quest Cohort Study|
- Cause of angina equivalent symptoms in patients with no coronary artery disease [ Time Frame: One day ] [ Designated as safety issue: No ]
- Prognosis of patients with angina equivalent symptoms and normal coronary arteries [ Time Frame: 10 years after baseline assessment ] [ Designated as safety issue: No ]
|Study Start Date:||July 1996|
|Estimated Study Completion Date:||July 2018|
|Estimated Primary Completion Date:||July 2018 (Final data collection date for primary outcome measure)|
All consecutive patients who had coronary angiography at the Luzerner Kantonsspital between July 1st 1996 and July 31st 2008 and who had no significant coronary stenoses (no coronary stenoses ≥ 50%) were recruited for this study. Patients are extensively examined during angiography using acetylcholine infusion and fast atrial pacing. According to the result of the additional invasive examination (vasospasm, vasoconstriction, vasodilation; symptoms during examination) a distinct diagnosis is attributed to the patients (small vessel disease, vasospastic disease, hypertensive heart disease, rhythm disorder, or extracardiac thoracic pain including pulmonary hypertension). Patients are followed-up after 10 years and prognosis of these patients is assessed (including mortality, cardiovascular events, re-angiography, functional status after 10 years).
Please refer to this study by its ClinicalTrials.gov identifier: NCT01318629
|Luzern, Switzerland, 6000|
|Principal Investigator:||Paul Erne, MD||Luzerner Kantonsspital|